Dirk Arnold
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies 156
- Cancer Treatment and Pharmacology 54
- Colorectal Cancer Surgical Treatments 34
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 34
- Pulmonary and Respiratory Medicine top 0.1%
- Gastric Cancer Management and Outcomes 89
- Lung Cancer Treatments and Mutations 29
- Gastroenterology top 0.5%
- Surgery top 0.1%
- Colorectal and Anal Carcinomas 41
-
- Genetic factors in colorectal cancer 30
- Co-authors
- Andrés CervantesEmmanuel TiretBernard NordlingerBengt GlimeliusEric Van CutsemRob Glynne‐JonesKarin HaustermansDavid Cunningham
- Journals
- Journal of Clinical Oncology (64 papers)Annals of Oncology (48 papers)BMC Cancer (10 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Dirk Arnold
252 papers receiving 16.8k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 11.4k
- Hepatology 1.9k
- Pulmonary and Respiratory Medicine 6.7k
- Gastroenterology 996
- Surgery 6.9k
Countries citing papers authored by Dirk Arnold
This map shows the geographic impact of Dirk Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Arnold more than expected).
Fields of papers citing papers by Dirk Arnold
This network shows the impact of papers produced by Dirk Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Arnold. The network helps show where Dirk Arnold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dirk Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 10 | |
| 7 | Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upbreakdown → | 2022 | 774 |
| 8 | 2022 | 0 | |
| 9 | 2022 | 7 | |
| 10 | 2018 | 32 | |
| 11 | Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2017 | 1290 |
| 12 | 2016 | 88 | |
| 13 | Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2016 | 471 |
| 14 | Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2016 | 757 |
| 15 | 2016 | 9 | |
| 16 | 2014 | 8 | |
| 17 | 2014 | 12 | |
| 18 | 2014 | 34 | |
| 19 | 2013 | 35 | |
| 20 | 2007 | 1 |
About Dirk Arnold
Dirk Arnold is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 271 papers that have together received 17.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (156 papers), Gastric Cancer Management and Outcomes (89 papers), Cancer Treatment and Pharmacology (54 papers), Colorectal and Anal Carcinomas (41 papers), Colorectal Cancer Surgical Treatments (34 papers), Hepatocellular Carcinoma Treatment and Prognosis (34 papers), Genetic factors in colorectal cancer (30 papers) and Lung Cancer Treatments and Mutations (29 papers). The work is most often cited by research in Oncology (11.4k citations), Hepatology (1.9k citations) and Pulmonary and Respiratory Medicine (6.7k citations). Dirk Arnold has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Andrés Cervantes, Emmanuel Tiret, Bernard Nordlinger, Bengt Glimelius, Eric Van Cutsem, Rob Glynne‐Jones, Karin Haustermans, David Cunningham, Marcel Verheij and William Allum. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, BMC Cancer, ESMO Open and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.